{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:37:05Z","timestamp":1786448225503,"version":"build-2736575974"},"reference-count":15,"publisher":"Hamad bin Khalifa University Press (HBKU Press)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Septic shock is a severe form of sepsis characterized by circulatory failure and organ dysfunction, often requiring vasopressor support to maintain adequate mean arterial pressure. Norepinephrine is the recommended first-line vasopressor, but new-onset atrial fibrillation (AF) is a common complication in septic shock patients receiving vasopressors, potentially influenced by vasopressor choice. This study compares the incidence of new-onset AF and related cardiac outcomes in septic shock patients treated with norepinephrine versus phenylephrine.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To compare the incidence of new-onset AF within 72 hours of vasopressor initiation in adult septic shock patients treated with norepinephrine versus phenylephrine.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A retrospective observational cohort study was conducted using the TriNetX database, including adult septic shock patients without prior AF who received either norepinephrine or phenylephrine. Propensity score matching balanced baseline characteristics across cohorts. The primary outcome was incidence of new-onset AF; secondary outcomes included cardioversion events, rate control medication use, other arrhythmias, and embolic stroke incidence. Outcomes were analyzed using Cox proportional hazards models and Kaplan\u2013Meier survival curves.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    After matching, 138,051 patients were included in each group. New-onset AF occurred in 0.3% of norepinephrine-treated patients versus 0.01% in the phenylephrine group (OR 3.05; 95% CI: 2.55\u20133.65;\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001). Norepinephrine use was also associated with significantly increased rates of electrical and pharmacological cardioversion, rate control medication utilization, other arrhythmias, and embolic stroke (all\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001). Kaplan\u2013Meier analysis confirmed higher AF incidence in the norepinephrine group (log-rank\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    In septic shock patients, norepinephrine is associated with a significantly higher risk of new-onset AF and related adverse cardiac events compared to phenylephrine. These findings suggest vasopressor choice may influence arrhythmia risk and highlight the need for prospective studies to guide optimal vasopressor selection and management strategies in this population.\n                  <\/jats:p>","DOI":"10.5339\/qmj.2026.50","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:11:16Z","timestamp":1786446676000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence of new-onset atrial fibrillation following phenylephrine vs. norepinephrine use in septic shock patients: A retrospective cohort study"],"prefix":"10.5339","volume":"2026","author":[{"given":"Laith","family":"Rhabneh","sequence":"first","affiliation":[{"name":"Internal Medicine Department, HMH Ocean University Medical Center, Brick, New Jersey, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2073-6619","authenticated-orcid":true,"given":"Ra\u2019ed","family":"Ababneh","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, HMH Ocean University Medical Center, Brick, New Jersey, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Dib","sequence":"additional","affiliation":[{"name":"Anesthesia Department, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qusai","family":"Alqudah","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, HCA Florida North Florida Hospital, Gainesville, Florida, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel Rahman","family":"Alwardat","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, King Abdullah University Hospital, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aloqaily","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, University of Maryland Midtown Campus, Baltimore, Maryland, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3277","reference":[{"issue":"Suppl 1:","key":"B1","series-title":"Acta Clin Croat","first-page":"67","article-title":"Sepsis definition: what\u2019s new in the treatment guidelines","volume":"61","author":"Srzi\u0107\n \nI","year":"2022;","unstructured":"Srzi\u0107\n \nI\n\n, \n\nNesek Adam\n \nV\n\n, \n\nTunji\u0107 Pejak\n \nD\n\n\n. \nSepsis definition: what\u2019s new in the treatment guidelines\n. \nActa Clin Croat\n. \n2022;\n61\nSuppl 1:\n67\n72\n. \n\nhttps:\/\/doi.org\/10.20471\/acc.2022.61.s1.11"},{"issue":"9:","key":"B2","series-title":"J Clin Med","first-page":"3188","article-title":"2023 update on sepsis and septic shock in adult patients: management in the emergency department","volume":"12","author":"Guarino\n \nM","year":"2023;","unstructured":"Guarino\n \nM\n\n, \n\nPerna\n \nB\n\n, \n\nCesaro\n \nAE\n\n, \n\nMaritati\n \nM\n\n, \n\nSpampinato\n \nMD\n\n, \n\nContini\n \nC\n\n\n\n. \n2023 update on sepsis and septic shock in adult patients: management in the emergency department\n. \nJ Clin Med\n. \n2023;\n12\n9:\n3188\n. \n\nhttps:\/\/doi.org\/10.3390\/jcm12093188"},{"issue":"15:","key":"B3","series-title":"Circulation","first-page":"e676","article-title":"Atrial fibrillation occurring during acute hospitalization: a scientific statement from the AHA","volume":"147","author":"Chyou\n \nJY","year":"2023;","unstructured":"Chyou\n \nJY\n\n, \n\nBarkoudah\n \nE\n\n, \n\nDukes\n \nJW\n\n, \n\nGoldstein\n \nLB\n\n, \n\nJoglar\n \nJA\n\n, \n\nLee\n \nAM\n\n\n\n. \nAtrial fibrillation occurring during acute hospitalization: a scientific statement from the AHA\n. \nCirculation\n. \n2023;\n147\n15:\ne676\ne698\n. \n\nhttps:\/\/doi.org\/10.1161\/CIR.0000000000001133"},{"issue":"2:","key":"B4","series-title":"Crit Care Med","first-page":"280","article-title":"Risk factors for new-onset atrial fibrillation in patients with sepsis: a systematic review and meta-analysis","volume":"47","author":"Bosch\n \nNA","year":"2019;","unstructured":"Bosch\n \nNA\n\n, \n\nCohen\n \nDM\n\n, \n\nWalkey\n \nAJ\n\n\n. \nRisk factors for new-onset atrial fibrillation in patients with sepsis: a systematic review and meta-analysis\n. \nCrit Care Med\n. \n2019;\n47\n2:\n280\n287\n. \n\nhttps:\/\/doi.org\/10.1097\/CCM.0000000000003560"},{"key":"B5","series-title":"J Crit Care","first-page":"133","article-title":"Predictors of dysrhythmias with norepinephrine use in septic shock","volume":"61:","author":"Wieruszewski\n \nED","year":"2021;","unstructured":"Wieruszewski\n \nED\n\n, \n\nJones\n \nGM\n\n, \n\nSamarin\n \nMJ\n\n, \n\nKimmons\n \nLA\n\n\n. \nPredictors of dysrhythmias with norepinephrine use in septic shock\n. \nJ Crit Care\n. \n2021;\n61:\n133\n137\n. \n\nhttps:\/\/doi.org\/10.1016\/j.jcrc.2020.10.023"},{"issue":"9:","key":"B6","series-title":"Am J Respir Crit Care Med","first-page":"1097","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial","volume":"199","author":"Permpikul\n \nC","year":"2019;","unstructured":"Permpikul\n \nC\n\n, \n\nTongyoo\n \nS\n\n, \n\nViarasilpa\n \nT\n\n, \n\nTrainarongsakul\n \nT\n\n, \n\nChakorn\n \nT\n\n, \n\nUdompanturak\n \nS\n\n\n\n. \nEarly use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial\n. \nAm J Respir Crit Care Med\n. \n2019;\n199\n9:\n1097\n1105\n. \n\nhttps:\/\/doi.org\/10.1164\/rccm.201806-1034OC"},{"issue":"2:","key":"B7","series-title":"West J Emerg Med","first-page":"196","article-title":"Norepinephrine in septic shock: a systematic review and meta-analysis","volume":"22","author":"Ruslan\n \nMA","year":"2021;","unstructured":"Ruslan\n \nMA\n\n, \n\nBaharuddin\n \nKA\n\n, \n\nNoor\n \nNM\n\n, \n\nYazid\n \nMB\n\n, \n\nNoh\n \nAYM\n\n, \n\nRahman\n \nA\n\n\n. \nNorepinephrine in septic shock: a systematic review and meta-analysis\n. \nWest J Emerg Med\n. \n2021;\n22\n2:\n196\n203\n. \n\nhttps:\/\/doi.org\/10.5811\/westjem.2020.10.47825"},{"issue":"9:","key":"B8","series-title":"N Engl J Med","first-page":"779","article-title":"SOAP II Investigators","volume":"362","author":"De Backer\n \nD","year":"2010;","unstructured":"De Backer\n \nD\n\n, \n\nBiston\n \nP\n\n, \n\nDevriendt\n \nJ\n\n, \n\nMadl\n \nC\n\n, \n\nChochrad\n \nD\n\n, \n\nAldecoa\n \nC\n\n\n\n. \nSOAP II Investigators\n. \nN Engl J Med\n. \n2010;\n362\n9:\n779\n789\n. \n\nhttps:\/\/doi.org\/10.1056\/NEJMoa0907118"},{"issue":"1:","key":"B9","series-title":"Circulation","first-page":"e1","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"149","author":"Joglar\n \nJA","year":"2024;","unstructured":"Joglar\n \nJA\n\n, \n\nChung\n \nMK\n\n, \n\nArmbruster\n \nAL\n\n, \n\nBenjamin\n \nEJ\n\n, \n\nChyou\n \nJY\n\n, \n\nCronin\n \nEM\n\n\n\n. \n2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation\n. \nCirculation\n. \n2024;\n149\n1:\ne1\ne156\n. \n\nhttps:\/\/doi.org\/10.1161\/CIR.0000000000001193"},{"issue":"7:","key":"B10","series-title":"PLoS One","first-page":"e0133664","article-title":"Norepinephrine-induced adrenergic activation increases atrial fibrillation duration in mice","volume":"10","author":"Suita\n \nK","year":"2015;","unstructured":"Suita\n \nK\n\n, \n\nFujita\n \nT\n\n, \n\nHasegawa\n \nN\n\n, \n\nCai\n \nW\n\n, \n\nJin\n \nH\n\n, \n\nPrajapati\n \nR\n\n\n\n. \nNorepinephrine-induced adrenergic activation increases atrial fibrillation duration in mice\n. \nPLoS One\n. \n2015;\n10\n7:\ne0133664\n. \n\nhttps:\/\/doi.org\/10.1371\/journal.pone.0133664"},{"issue":"5:","key":"B11","series-title":"J Mol Cell Cardiol","first-page":"988","article-title":"Arrhythmogenic coupling between Na+-Ca2+ exchanger and IP3 receptor in rat pulmonary vein cardiomyocytes","volume":"52","author":"Okamoto\n \nY","year":"2012;","unstructured":"Okamoto\n \nY\n\n, \n\nTakano\n \nM\n\n, \n\nOhba\n \nT\n\n, \n\nOno\n \nK\n\n\n. \nArrhythmogenic coupling between Na+-Ca2+ exchanger and IP3 receptor in rat pulmonary vein cardiomyocytes\n. \nJ Mol Cell Cardiol\n. \n2012;\n52\n5:\n988\n997\n. \n\nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2012.01.007"},{"issue":"4:","key":"B12","series-title":"BMJ Open","first-page":"e090404","article-title":"Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trial","volume":"15","author":"Labb\u00e9\n \nV","year":"2025;","unstructured":"Labb\u00e9\n \nV\n\n, \n\nDesnos\n \nC\n\n, \n\nPreau\n \nS\n\n, \n\nDoyen\n \nD\n\n, \n\nContou\n \nD\n\n, \n\nBagate\n \nF\n\n\n\n. \nRisk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trial\n. \nBMJ Open\n. \n2025;\n15\n4:\ne090404\n. \n\nhttps:\/\/doi.org\/10.1136\/bmjopen-2024-090404"},{"issue":"11:","key":"B13","series-title":"Intensive Care Med","first-page":"1181","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans\n \nL","year":"2021;","unstructured":"Evans\n \nL\n\n, \n\nRhodes\n \nA\n\n, \n\nAlhazzani\n \nW\n\n, \n\nAntonelli\n \nM\n\n, \n\nCoopersmith\n \nCM\n\n, \n\nFrench\n \nC\n\n\n\n. \nSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021\n. \nIntensive Care Med\n. \n2021;\n47\n11:\n1181\n1247\n. \n\nhttps:\/\/doi.org\/10.1007\/s00134-021-06506-y"},{"issue":"6:","key":"B14","series-title":"Saudi Pharm J","first-page":"102094","article-title":"Beta-blockers with vasopressors and inotropes in septic shock: systematic review and meta-analysis","volume":"32","author":"Al Sulaiman\n \nK","year":"2024;","unstructured":"Al Sulaiman\n \nK\n\n, \n\nAlkofide\n \nHA\n\n, \n\nAlFaifi\n \nME\n\n, \n\nAljuhani\n \nO\n\n, \n\nAlharthi\n \nA\n\n, \n\nAljuhani\n \nS\n\n\n\n. \nBeta-blockers with vasopressors and inotropes in septic shock: systematic review and meta-analysis\n. \nSaudi Pharm J\n. \n2024;\n32\n6:\n102094\n. \n\nhttps:\/\/doi.org\/10.1016\/j.jsps.2024.102094"},{"issue":"5:","key":"B15","series-title":"Crit Care","first-page":"R204","article-title":"Pattern of brain injury in acute septic shock","volume":"17","author":"Polito\n \nA","year":"2013;","unstructured":"Polito\n \nA\n\n, \n\nEischwald\n \nF\n\n, \n\nMaho\n \nAL\n\n, \n\nPolito\n \nA\n\n, \n\nAzabou\n \nE\n\n, \n\nAnnane\n \nD\n\n\n\n. \nPattern of brain injury in acute septic shock\n. \nCrit Care\n. \n2013;\n17\n5:\nR204\n. \n\nhttps:\/\/doi.org\/10.1186\/cc12899"}],"container-title":["Qatar Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/3\/article-50.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/3\/article-50.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/3\/article-50.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:11:16Z","timestamp":1786446676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/3\/article-50.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5339\/qmj.2026.50","relation":{},"ISSN":["2227-0426"],"issn-type":[{"value":"2227-0426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}